Semaglutide works by mimicking the GLP-1 receptor agonist that helps control blood sugar, suppress appetite, and slow stomach emptying resulting in weight loss and reducing cardiovascular events
This binding activates adenylyl cyclase, increases intracellular cAMP, and triggers pulsatile synthesis and release of endogenous human growth hormone (GH) in a manner that mimics the bodys natural episodic secretion
This is a massive play to maintain their lead in the space
3.3.5 Other efficacy of GLP-1 RAs in MASLD Anthropometric measurements, including body weight, BMI, WC, SAT, and VAT, as well as inflammatory factors, such as CRP, were also included in the meta-analyses (Supplementary Table S6)